Based on these observations, we aimed to determine whether the concentration of total plasmatic tPA levels could serve as a valuable biomarker for distinguishing between hemorrhagic stroke, ischemic stroke, and stroke mimics. The gene discussed is PLAT; the disease is ischemic stroke.